Struggle with significant insulin resistance
For instance, research has shown that topically applying it to the skin can shield skin cells from oxidative damage induced by UV radiation
Care at Geneva is guided by: In-house lab testing to assess metabolic health, insulin sensitivity, and relevant risk factors Metabolic and hormone evaluation to understand drivers of appetite, weight regulation, and energy balance Regular physician follow-ups to monitor response, tolerance, and long-term progress Flexible medication pathways that allow adjustments based on how each patient responds over time Rather than defaulting to a single medication, Geneva physicians evaluate whether a patient is more likely to benefit from a traditional GLP-1 medication or from tirzepatide
JACQUES MATTE Dairy and Swine R & D Centre, Agriculture and Agri-Food Canada, Sherbrooke (Lennoxville), Quebec, Canada
NICE guidance specifies a maximum treatment duration of two years in this setting